PUBLISHER: The Business Research Company | PRODUCT CODE: 2035834
PUBLISHER: The Business Research Company | PRODUCT CODE: 2035834
At-home dermatology devices are personal care tools designed to allow individuals to monitor, treat, or improve skin health outside a clinical setting. They use technologies such as lasers, light therapy, microcurrents, or diagnostic sensors to address issues like acne, wrinkles, hyperpigmentation, or hair growth.
The primary product types of at-home dermatology devices include light therapy devices, microdermabrasion devices, laser devices, radiofrequency devices, microneedling devices, and other types. Light therapy devices use specific wavelengths of light to treat skin conditions such as acne, psoriasis, and signs of aging. These solutions are distributed through online stores, pharmacies, specialty stores, and other channels. Applications include acne treatment, hair removal, skin rejuvenation, wrinkle reduction, psoriasis, and other areas, serving end users such as individuals and home care settings.
Tariffs on imported electronic components, laser modules, and sensor technologies are impacting the at-home dermatology device market by raising production and retail costs, particularly affecting laser devices, light therapy devices, and microneedling kits. Regions such as North America, Europe, and Asia-Pacific that rely heavily on imported components are most affected. While tariffs increase device costs, they also incentivize local manufacturing, support regional supply chains, and encourage development of cost-effective and innovative home dermatology solutions, offering long-term market growth opportunities.
The at-home dermatology devices market research report is one of a series of new reports from The Business Research Company that provides at-home dermatology devices market statistics, including at-home dermatology devices industry global market size, regional shares, competitors with a at-home dermatology devices market share, detailed at-home dermatology devices market segments, market trends and opportunities, and any further data you may need to thrive in the at-home dermatology devices industry. This at-home dermatology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The at-home dermatology devices market size has grown rapidly in recent years. It will grow from $9.68 billion in 2025 to $10.9 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to rising consumer awareness of skin health, growing demand for anti-aging solutions, increasing popularity of non-invasive home treatments, advancements in laser and light therapy technology, expansion of e-commerce channels for skincare devices.
The at-home dermatology devices market size is expected to see rapid growth in the next few years. It will grow to $17.7 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to increasing integration of AI and diagnostic sensors in devices, rising adoption of personalized skin treatment solutions, growth of online and subscription-based distribution models, expansion of multi-functional and combination therapy devices, increasing focus on safety and regulatory compliance for home-use dermatology tools. Major trends in the forecast period include increasing adoption of portable at-home dermatology devices, rising demand for combination skincare therapy devices, growing integration of light and laser-based treatment devices, expansion of automated microneedling and serum delivery systems, rising focus on online and direct-to-consumer distribution channels.
The rising incidence of skin-related disorders is projected to drive the growth of the at-home dermatology devices market in the coming years. Skin-related disorders refer to conditions affecting the skin, including eczema, dermatitis, psoriasis, and other chronic or acute inflammatory diseases. The occurrence of skin-related disorders is increasing due to lifestyle changes such as unhealthy diets, heightened stress levels, reduced physical activity, and greater exposure to environmental pollutants, which can trigger or aggravate conditions such as eczema, acne, and psoriasis. At-home dermatology devices allow individuals to proactively manage skin-related disorders by providing real-time monitoring, customized treatment application, and progress tracking, thereby minimizing reliance on in-person consultations while enhancing skin health outcomes. For instance, in August 2023, Skin Health Institute Inc., an Australia-based non-profit organization, reported that in Australia, psoriasis affects an estimated 2-3% of the population, underscoring it as a relatively common skin condition. Therefore, the rising incidence of skin-related disorders is driving the growth of the at-home dermatology devices market.
Key companies operating in the At-Home Dermatology Devices market are concentrating on developing innovative products such as at-home microneedle injectable devices to deliver convenient, effective, and self-administered treatments for common skin conditions. At-home microneedle injectable devices are compact instruments designed to administer precise doses of medication directly into the skin, helping to reduce inflammation, treat acne or other dermatologic conditions, and provide clinic-level outcomes conveniently at home. For example, in October 2025, Indomo Therapeutics Inc., a US-based clinical-stage company, launched ClearPen, an investigational at-home injectable candidate for treating inflammatory acne lesions. ClearPen integrates a proprietary microneedle delivery device with triamcinolone acetonide, a corticosteroid aligned with American Academy of Dermatology guidelines. The device facilitates precise, low-dose intradermal injections that reduce inflammation and lesion size, enabling patients to self-administer treatment safely at home. Its design prioritizes ease of use, accuracy, and convenience compared with conventional in-office intralesional injections. Beyond acne, Indomo seeks to broaden the platform for other corticosteroid-responsive conditions, such as keloids and hidradenitis suppurativa, expanding access to timely dermatologic care.
In October 2024, CurrentBody Ltd, a UK-based beauty technology company, acquired Tria Beauty, Inc. for an undisclosed amount. With this acquisition, CurrentBody Ltd intends to broaden its portfolio of at-home beauty devices and reinforce its leadership in clinically validated, consumer-oriented aesthetic technologies. Tria Beauty Inc. is a US-based beauty technology company specializing in the development of FDA-approved at-home laser hair removal and skin rejuvenation devices.
Major companies operating in the at-home dermatology devices market are Procter & Gamble Co., Panasonic Corporation, L'Oreal S.A., Koninklijke Philips N.V., Nu Skin Enterprises Inc., YA-MAN Ltd., Therabody Inc., FOREO AB, CurrentBody Ltd., Home Skinovations Ltd., Project E Beauty Inc., The Beauty Tech Group Inc., LightStim Inc., Beurer GmbH, PMD Beauty Inc., ZIIP Beauty Inc., Microderm GLO LLC, BSG Aesthetics Solutions Inc., Nood Ventures LLC, Reviva Labs Inc., Kenzzi Limited, Homiley Brands LLC, Nooance Inc.
North America was the largest region in the at-home dermatology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the at-home dermatology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the at-home dermatology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The at-home dermatology devices market consists of sales of handheld skin analyzers, portable acne treatment wands, home use skin tightening and contouring tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
At-Home Dermatology Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses at-home dermatology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for at-home dermatology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The at-home dermatology devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.